The Effect of Duration and Frequency of Walking Exercise on Cognitive Functions
1 other identifier
interventional
35
1 country
1
Brief Summary
Physical activity is very important for staying healthy and improving how well our brain works. Walking is a simple and easy way to exercise that can help people of all ages feel better physically and mentally. It's affordable, easy to do, and doesn't require special equipment. Walking can improve memory, thinking speed, and problem-solving skills, which are important for everyday life. This study looks at whether doing shorter walks more often (like three 10-minute walks a day) is as good for the brain as doing one longer walk (one 30-minute walk a day). This is important because many people find it hard to fit long exercise sessions into their day due to busy schedules, health issues, or personal preferences. By understanding which way of walking helps the brain the most, doctors and patients can choose exercise plans that are easier to stick to and still improve thinking skills. This study will compare these two walking routines over 6 weeks to see how they affect brain health. This clinical trial investigates the cognitive effects of two different walking exercise protocols over a 6-week period. Participants will either complete three daily 10-minute walking sessions or a single continuous 30-minute walking session. The study aims to determine whether shorter, more frequent exercise sessions provide cognitive benefits comparable to a longer, single session. Outcomes will focus on improvements in memory, processing speed, and executive function. Findings will inform recommendations for accessible and flexible exercise programs to enhance cognitive health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 16, 2024
CompletedFirst Submitted
Initial submission to the registry
August 6, 2025
CompletedFirst Posted
Study publicly available on registry
August 13, 2025
CompletedAugust 13, 2025
August 1, 2025
2 months
August 6, 2025
August 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Digit Symbol Substitution Test (DSST) Score
Main endpoint; large effect size; reflects executive function \& speed
Baseline and 6 weeks post-intervention
Secondary Outcomes (1)
Change in Stroop Test
Baseline and 6 weeks post-intervention
Study Arms (2)
Short-Duration Walking Group
EXPERIMENTALParticipants walked 3 sessions of 10 minutes per day, five days a week for 6 weeks, at 60% of their maximum heart rate.
Long-Duration Walking Group
ACTIVE COMPARATORParticipants walked 1 continuous 30-minute session per day, five days a week for 6 weeks, at 60% of their maximum heart rate.
Interventions
articipants performed three 10-minute walking sessions per day, 5 days per week for 6 weeks, at 60% of their maximum heart rate on a treadmill.
Participants performed one continuous 30-minute walking session per day, 5 days per week for 6 weeks, at 60% of their maximum heart rate on a treadmill.
Eligibility Criteria
You may qualify if:
- Female
- Aged between 18 and 25 years
- Sedentary lifestyle, defined as taking \<5000 steps/day in the previous week
- Non-smoker
- Having a work or school schedule that allows consistent participation in the 6-week walking program
- Able to walk on a treadmill
- Provided written informed consent
You may not qualify if:
- Body Mass Index (BMI) ≥ 30 kg/m²
- Participation in another regular exercise program during the study period
- Neurological conditions (e.g., stroke, epilepsy)
- Severe cardiovascular conditions (e.g., heart failure, arrhythmias)
- Any physical limitation that prevents safe walking on a treadmill
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University
Ankara, Cankaya, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants were not blinded (they knew their group) Investigators (those conducting and monitoring the intervention) were blinded Outcomes assessors (evaluating cognitive tests) were blinded
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
August 6, 2025
First Posted
August 13, 2025
Study Start
January 1, 2024
Primary Completion
February 16, 2024
Study Completion
February 16, 2024
Last Updated
August 13, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
Demographic data: age, height, weight, BMI Group assignment: 10-minute or 30-minute walking group Cognitive test scores: Stroop Test Word (STW) Stroop Test Color (STC) Stroop Test Word-Color (STWC) Digit Symbol Substitution Test (DSST) Pre- and post-intervention scores for all cognitive assessments